- FDA panel confronting peptide controversyToday's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."STAT · 1d ago↗ source
- A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribingHas a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…STAT · 1d ago↗ source
- STAT+: Vote on key federal health nominee delayed amid questions over vaccine viewsSean Kaufman, nominated to run ASPR, has a track record of questioning the safety of vaccines.STAT · 1d ago↗ source